Loading
Latest filing published 07 Aug 2026 for Braveheart Bio, Inc., €65k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David I. Malek has a single filing on record, published on 7 August 2026: an open-market purchase of €65k in Braveheart Bio, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration